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Cytoplasmic accumulation and nuclear clearance of TDP-43 characterize familial and sporadic forms of
amyotrophic lateral sclerosis and frontotemporal lobar degeneration, suggesting that either loss or gain of
TDP-43 function, or both, cause disease formation. Here we have systematically compared loss- and gain-
of-function of Drosophila TDP-43, TAR DNA Binding Protein Homolog (TBPH), in synaptic function and
morphology, motor control, and age-related neuronal survival. Both loss and gain of TBPH severely affect
development and result in premature lethality. TBPH dysfunction caused impaired synaptic transmission
at the larval neuromuscular junction (NMJ) and in the adult. Tissue-specific knockdown together with electro-
physiological recordings at the larval NMJ also revealed that alterations of TBPH function predominantly
affect pre-synaptic efficacy, suggesting that impaired pre-synaptic transmission is one of the earliest
events in TDP-43-related pathogenesis. Prolonged loss and gain of TBPH in adults resulted in synaptic
defects and age-related, progressive degeneration of neurons involved in motor control. Toxic gain of
TBPH did not downregulate or mislocalize its own expression, indicating that a dominant-negative effect
leads to progressive neurodegeneration also seen with mutational inactivation of TBPH. Together these
data suggest that dysfunction of Drosophila TDP-43 triggers a cascade of events leading to loss-of-function
phenotypes whereby impaired synaptic transmission results in defective motor behavior and progressive
deconstruction of neuronal connections, ultimately causing age-related neurodegeneration.
INTRODUCTION
Tar DNA binding protein of 43 kDa (TDP-43) has been iden-
tified as the major disease protein present in cytoplasmic
inclusions in amyotrophic lateral sclerosis (ALS) and fronto-
temporal lobar degeneration (FTLD). Full length TDP-43
protein as well as 25 kDa, C-terminal fragments were found
to be hyper-phosphorylated and ubiquitinated in aggregates
present in affected brain and spinal cord of ALS and FTLD
cases (1,2). TDP-43 inclusions are found as secondary histo-
pathological feature in other neurodegenerative disorders in-
cluding Alzheimer’s, Parkinson’s and Huntington’s disease,
thereby defining a novel proteinopathy (3,4). Dominant
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missense mutations in the TARDBP gene have been identified
in familial and sporadic cases of ALS and FTLD (5–8), indi-
cating that TDP-43 dysfunction may cause disease formation.
TDP-43 encodes an evolutionarily conserved protein com-
prising a bipartite nuclear localization signal, two RNA recog-
nition motifs (RRMs), a nuclear export signal, a glycine and
glycine/glutamine/asparagine-rich C-terminal region. The
C-terminus resembles a prion-like domain (9,10) predominantly
mutated in TDP-43-related ALS and FTLD cases (11,12). In
vitro studies showed that TDP-43 is involved in transcriptional
regulation, RNA biogenesis and splicing (13). The C-terminal
domain of TDP-43 regulates tissue-specific gene expression,
transcriptional repression, and alternative splicing, and is essen-
tial for binding to heterogeneous nuclear ribonucleoproteins
involved in microRNA and mRNA biogenesis, as well as
RNA turnover (12,13).
The pathophysiological role of TDP-43 has been addressed
in cell culture and animal models using mutation, alteration
or expression of disease-specific variants of TDP-43 and
its homologs in worms, flies, zebrafish, mice and rats
(11,12,14). These studies revealed that post-translational
modification (phosphorylation, ubiquitylation), truncation,
mislocalization, nuclear clearance, cytoplasmic accumulation
and defective autoregulation can all impact either directly or
indirectly onto TDP-43 toxicity (12). The resulting phenotypes
include lethality or reduced lifespan, defects in axogenesis and
neurite branching, altered synaptic morphology, axon and
neuron degeneration, astrogliosis, defective fat metabolism,
impaired motor behavior and cognitive deficits (11,14). The
available data suggest that TDP-43 toxicity is either directly
or indirectly related to disease formation. So far, however,
no consensus has emerged as to whether loss (i.e. nuclear
clearance) or toxic gain (i.e. cytoplasmic accumulation) of
TDP-43, or both, are causally related to disease onset and
progression. Moreover, despite the fact that a large number
of TDP-43 RNA targets have been identified (15–18), the
initiating events and pathogenic pathways underlying TDP-43-
mediated neurodegeneration remain to be identified.
Here we show that similar to its human homolog, Drosophila
TDP-43, TAR DNA binding protein homolog (TBPH), is
expressed in neurons, glia and muscle cells. Both loss of func-
tion and overexpression of TBPH result in decreased viability,
impaired synaptic transmission, defective locomotion and
age-related progressive neurodegeneration. Together these data
suggest that both increased and decreased levels of TDP-43 ini-
tiate a loss-of-function phenotype, resulting in decreased neur-
onal viability and subsequent degenerative cell loss that
characterize motor neuron diseases like ALS and FTLD.
RESULTS
Drosophila TDP-43, TBPH, is expressed in neurons,
glia and muscle cells
BLAST search of the annotated Drosophila melanogaster
genome identified two genes with sequence similarities to
TARDBP/TDP-43, namely TBPH (19) and CG7804.
Genomic sequence analysis revealed that the predicted six iso-
forms of TBPH are encoded by 5–6 exons, whereas the coding
region of CG7804 is intronless with sequence similarity to
exon 1–4 of TBPH. The differences in exon–intron structure
and coding sequence similarities between CG7804 and TBPH
suggest that CG7804 is paralogous to TBPH and likely to be a
newly evolved retrogene that derived from TBPH rather than
TARDBP (20). Moreover, in contrast to TBPH, CG7804 is
not expressed in CNS and lacks a prion-like C-terminus that
is predominantly mutated in ALS and FTLD (Supplementary
Material, Fig. S1). We therefore focused on TBPH.
We generated polyclonal antibodies against TBPH-specific
peptide sequences. Western blot analysis of control tissue
identified a 58 kDa protein encoded by TBPH which was
absent in deletions uncovering the genomic locus (Supplemen-
tary Material, Fig. S2); we did not detect any cleavage pro-
ducts, TBPH fragments, dimers nor band that indicates
post-translational modifications (Supplementary Material,
Fig. S2). Whole-mount immunocytochemistry revealed that,
similar to human TDP-43, TBPH is expressed throughout de-
velopment and adulthood in the nucleus of neurons, glia and
muscle cells (Fig. 1). Perinuclear, cytoplasmic TBPH expression
was detectable in post-mitotic neurons (Fig. 1L–O), although
immunoreactivity was less intense than nuclear anti-TBPH la-
beling. These data suggest that similar to TDP-43, and predicted
by nuclear localization and export signals (21,22), TBPH is
predominantly localized to the nucleus but also shuttles into
the cytoplasm.
Both loss and gain of TBPH affect survival
and motor behavior
To study TDP-43 dysfunction in Drosophila, we generated
specific loss- and gain-of-function alleles of TBPH. Imprecise
P-element excision resulted in two independent deletions that
removed the promoter region and start codon, or the promoter
region, start codon, exons 1–3 and parts of exon 4 coding for
the TBPH RRMs (Fig. 2A). RT–PCR and western blot ana-
lyses determined the absence of TBPH RNA and protein
(Fig. 2B and C). For tissue-specific TBPH LOF, we generated
two independent hairpin-loop UAS-RNAi lines that target
exon 5 of all predicted TBPH isoforms (Supplementary Mater-
ial, Fig. S3). BLAST search confirmed that our chosen target
sequences do not detect off-targets, in contrast to other avail-
able TBPH RNAi lines, and western blot analysis revealed that
Tub-Gal4 driven UAS-TBPH-RNAi is able to knock down en-
dogenous TBPH protein expression below detection level
(Supplementary Material, Fig. S3).
For gain of TBPH function (GOF), several independent
UAS lines were generated with single inserts on different
chromosomal locations. Expression efficacy was tested using
eye-specific GMR-Gal4 activation. Western blot analysis
revealed that GMR.TBPH showed increased amounts of
TBPH protein (Fig. 2D) comparable among different insertion
lines (Fig. 2E). Targeted misexpression resulted in excessive
accumulation of TBPH both in the nucleus and cytoplasm
(Supplementary Material, Fig. S4).
Analysis of zygotic TBPH LOF (TBPH2/2) and Gal4-
mediated GOF mutants revealed that both affect development
and lifespan: only 10–20% of progeny eclosed as adult while
the majority of mutant cases died during late larval/pupal
stages (Fig. 3A). Adult TBPH2/2 mutant and pan-neuronal
Gal4-specific ELAV.TBPH GOF flies were characterized by
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shortened lifespan, with TBPH2/2 adults dying around day 7
and pan-neuronal Gal4-specific ELAV.TBPH flies dying
around day 35, when compared with wild-type controls with
an average lifespan of 80 days (23,24) (data not shown).
Affected larvae exhibited impaired peristalsis and defective
locomotion, which was more severe in TBPH2/2 LOF
mutants compared with pan-neuronal Gal4-specific ELAV.
TBPH GOF (Fig. 3B). Adult TBPH2/2 LOF mutant escapers
and pan-neuronal Gal4-specific ELAV.TBPH GOF flies were
characterized by inexistent or severely impaired innate escape
and climbing behaviors (Fig. 3C).
To further investigate motor behavior, we used an open-
field paradigm together with video-assisted motion tracking
(23,24) (Fig. 3D) and compared adult TBPH2/2 mutant
LOF escapers with EB1-Gal4-mediated UAS-TBPH GOF
flies targeting TBPH to ellipsoid body neurons of the central
complex that are upper motor neurons due to their prominent
role in the higher control of locomotion (25). Analysis of adult
TBPH2/2 mutant LOF escapers and EB1.TBPH GOF flies
revealed severely reduced walking activity and distance trav-
eled; motor activity remained low over time with only
TBPH2/2 flies walking slower (Fig. 3D–H). In addition,
both LOF and GOF flies were characterized by severe gait ab-
normalities (Fig. 3I). These data suggest that TBPH dysfunc-
tion affects lifespan and motor behavior.
To confirm that the phenotypes observed in homozygous
TBPH2/2 LOF flies were indeed due to the absence of
TBPH, we carried out a complementation test using a defi-
ciency line uncovering the genomic region of chromosome
2R (Df(2R)106) including the TBPH locus, which revealed
early larval lethality suggesting non-complementation. In add-
ition and to rule out hidden second-site mutations, we first ana-
lyzed heteroallelic combinations using our TBPHDD96 and
TBPHDD100 alleles together with a recently reported deletion
(26), which also revealed non-complementation. Secondly,
we generated a genomic TBPH construct covering the entire
coding region of TBPH as well as 3′- and 5′- regions upstream
of the TBPH locus (Supplementary Material, Fig. S5). To
analyze its rescue potential, we integrated TBPHgenomic on
3R using the attP86Fb landing site and crossed it into the
TBPHDD96 mutant background. Analysis of homozygous
TBPHDD962/2 flies carrying one or two copies of TBPHgenomic
revealed full rescue. Thus, development, larval locomotion,
eclosion, adult climbing, walking and tripod gait phenotypes
Figure 1. TBPH is expressed in neurons, glia and muscle cells. (A–E) Endogenous TBPH expression was examined at the neuromuscular junction of muscle
group 6/7 of abdominal segment II in w1118 wandering third instar larvae. TBPH is expressed in the nucleus of muscle cells (C–E). Images are z-projections of a
10 mm area scanned in 2 mm steps. (F–J) Endogenous TBPH expression was examined in the adult brain of flies expressing membrane-bound GFP in ellipsoid
body neurons of the central brain that are considered to be upper motor neurons [EB1.mCD8::GFP; CNS hemisphere shown in (J), the dotted white box corre-
sponds to (F–I)]. TBPH is expressed in neurons (F and G, arrow) and glia (H, arrowhead) throughout the adult brain, including ellipsoid body neurons. Images
are single z-slices taken in 1 mm steps. (K–O) TBPH expression is also seen in perinuclear regions of ellipsoid body neurons as shown by its co-localization with
membrane bound mCD8::GFP (white arrowheads). Images are single z-sections taken in 1.5 mm steps. Scale bars; 50 mm (A–E); 10 mm (F–I, K–O).
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of homozygous TBPHDD96 mutants were all restored in
TBPHDD962/2; TBPHgenomic flies (Supplementary Material,
Fig. S6). Together, these data suggest that the observed
loss-of-function phenotypes are indeed due to the loss of
TBPH, and hence our TBPH 2/2 mutants represent bona
fide TBPH null alleles.
TBPH dysfunction does not affect synapse morphology
but function
To determine the cause of TBPH-mediated behavioral pheno-
types, we analyzed whether TBPH dysfunction results in
muscle defects. Phalloidin staining of either larval L3 or
adult day 2 TBPH2/2 muscle preparations revealed a
muscle pattern indistinguishable of wild-type or heterozygous
TBPH+/2 controls (data not shown). Next we investigated
whether TBPH dysfunction may cause alterations of NMJ
synapse structure and morphology, as previously suggested
(27–30). We used a collection of synaptic markers (31) in-
cluding Fasciclin II (FasII), involved in synapse development
and plasticity; Bruchpilot (NC82), a component of the synaptic
active zone of neurotransmitter release; synaptotagmin (Syt)
involved in membrane traffic and calcium-dependent neuro-
transmitter release; Futsch, a pre-synaptic cytoskeletal
protein that binds microtubles and regulates synaptic growth
and dendritic morphology; and Neuroglian (Nrg), a cell
surface, transmembrane adhesion molecule involved in
motor neuron pathfinding. Larval NMJ preparations were
double-labeled for synaptic proteins and horse radish peroxid-
ase (HRP) that visualizes axons, dendrites and synaptic
boutons in Drosophila. However, for all of the synaptic pro-
teins examined, none were found to be mislocalized or
absent in TBPH2/2 LOF larvae compared with age-matched
w1118 controls (Supplementary Material, Fig. S7). A quantita-
tive analysis of HRP-labeled synaptic boutons and active zone
puncta immunolabeled by anti-Bruchpilot, did not reveal any
indication for alterations in the number of synaptic boutons
or anti-Bruchpilot positive active zones in homozygous
TBPHDD962/2 LOF larvae compared with age-matched
w1118 controls (Supplementary Material, Fig. S8). These data
suggest that the observed TBPH-related larval motor pheno-
types are not caused by morphological defects, mislocalization
or loss of selected proteins involved in synapse formation and
maintenance.
We then carried out electrophysiological recordings of cases
and controls to address whether TBPH-mediated behavioral
phenotypes might be caused by defects in synaptic efficacy
and function. Electrophysiological recordings made at the
NMJ of homozygous TBPHDD962/2 LOF and pan-neuronal
Gal4-mediated ELAV.TBPH GOF L3 larvae revealed a de-
crease in both the amplitude and frequency of miniature exci-
tatory junction potentials (mEJPs) in the homozygous
loss-of-function background. Low-frequency (0.2 Hz) stimula-
tion of the NMJ showed no difference in evoked excitatory
junction potential (EJP) amplitudes. As a consequence of the
changed mini amplitude but unaltered EJP amplitude there
was an increase in the quantal content in TBPH LOF but not
in ELAV.TBPH GOF (Fig. 4A and B). No differences were
seen during high-frequency stimulation between cases and
controls (data not shown).
We also recorded electroretinograms (ERGs) from adult
TBPH LOF and GOF cases compared with appropriate con-
trols. Both white-eyed TBPH2/2 LOF and w1118 control
Figure 2. Loss- and gain-of-function alleles of theDrosophilaTDP-43 homolog
TBPH. (A–C) TBPH null mutant alleles and (D, E) UAS-TBPH overexpression
alleles. (A) TBPH null mutant alleles (TBPHDD100 and TBPHDD96) were gener-
ated by imprecise P-element excision. Two types of deletion mutant were gen-
erated lacking distinct sections of the TBPH genomic region. The TBPHDD100
allele is lacking the promoter region of TBPH, including the start codon. The
TBPHDD96 allele is lacking a larger amount of gDNA including the promoter
region, the start codon and bases encoding the RNA recognition motifs
(RRMs). (B) RT–PCR revealed lack of TBPH mRNA in homozygous TBPH
mutants. Ribosomal protein L32 (RPL32) was used as loading control.
Control genotype: w1118. (C) TBPHDD100 and TBPHDD96 mutant alleles are
protein null, as revealed by the absence of the TBPH-specific 58 kDa protein
band present in w1118 flies (control); shown is a western blot using protein
extracts from six fly heads blotted with anti-TBPH antibody. (D) Western blot
analysis of GMR-Gal4 driven UAS-TBPH shows excess TBPH protein expres-
sion in adult heads. Two different UAS-TBPH lines with insertion on different
chromosomes (#763 on II, #765 on III) show comparable expression levels.
(E) Quantification of GMR.TBPH shows a dramatic increase in TBPH
protein levels. Western blot TBPH signal intensities were normalized against
b-Tubulin. Mean and SEM are shown.
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revealed similar responses to blue light pulses with no differ-
ences in peak–peak amplitude of the ERG. Moreover, the
ERG amplitude of red-eyed GMR.TBPH-RNAi and
OregonR were indistinguishable, also when compared
between 1- and 5-day-old flies (Fig. 4C and D). We then
examined the off-transient and plotted their size as a function
of the maintained photoreceptor response. On average, data
points from both TBPH LOF strains, TBPH2/2 and GMR.-
TBPH-RNAi flies, were above those from controls (Fig. 4E).
We tested the null hypothesis that data points were distributed
evenly above and below the control regression line between
maintained ERG potential and off-transient, which revealed
significant deviation for both TBPH2/2 and GMR.-
TBPH-RNAi. Moreover, we compared the size of the off-
transient recorded in both TBPH LOF lines with that estimated
from the control regression line which revealed 15 and 25%
reduction in the off-transient in TBPH2/2 and GMR.-
TBPH-RNAi, respectively. As positive control, we blocked
synaptic transmission in the retina using GMR.Shibire-RNAi,
the Drosophila homolog of Dynamin involved in synaptic
transmission (32), which resulted in completely abolished off-
transient (Fig. 4C) with data points significantly above the
wild-type regression line (Fig. 4E).
We also recorded ERGs from TBPH GOF flies where
Drosophila TDP-43 was over-expressed in the eye. TBPH/
w- controls showed an ERG in response to blue light
pulses like wild-type, whereas GMR/w- flies showed a
smaller response. In contrast, GMR.TBPH GOF flies
showed a very small response, with no off/on transients
visible (Fig. 4F and G), suggesting reduced synaptic signal-
ing. Taken together these data suggest that both TBPH LOF
and GOF affect synaptic efficacy and function, which is also
supported by an impaired innate escape response (Fig. 3C
and Supplementary Material, Fig. S9). The observed differ-
ential effects on synaptic efficacy and function in TBPH
LOF and GOF suggest that Drosophila TDP-43 dysfunction
either impairs post-synaptic efficacy or alters the size or
loading of synaptic vesicles, which is consistent with the
observed behavioral phenotypes of TBPH LOF and GOF
(Fig. 3).
Pre-synaptic deficits are early phenotypes
of dysfunctional TBPH
To gain further insights into TBPH-related synaptic transmis-
sion defects, we wondered whether TBPH dysfunction at the
larval NMJ affects pre- or post-synaptic efficiency, or both.
To address this question, we manipulated TBPH levels in a
tissue-specific manner and focused on Gal4-mediated TBPH
knockdown by using UAS-TBPH-RNAi in combination with
UAS-Dicer-2 expression, which enhances knockdown effi-
ciency (33). For pre-synapse-specific knockdown at the
larval NMJ, we carried out pan-neuronal Gal4-mediated
ELAV.Dcr2, TBPH-IR knockdown, and for post-synaptic
TBPH knockdown, we used muscle-specific, Gal4-mediated
BG57.Dcr2, TBPH-IR knockdown, in both cases utilizing re-
portedly strong and specific Gal4 drivers (34,35). Effects of
pre- or post-synaptic TBPH-RNAi were analyzed using elec-
trophysiological recordings at the L3 larval NMJ (Supplemen-
tary Material, Fig. S10).
Recordings at the NMJ of pan-neuronal Gal4-mediated
ELAV.Dcr2, TBPH-IR knockdown larvae revealed a de-
crease in both the amplitude and frequency of mEJPs. Low
frequency (0.2 Hz) stimulation of the NMJ showed no differ-
ence in evoked EJP amplitudes. As a consequence of the
changed mini amplitude but unaltered EJP amplitude, we
observed an increase in the quantal content in ELAV.Dcr2,
TBPH-IR larvae (Supplementary Material, Fig. S10A and
B). These data suggest that, similar to recordings at the NMJ
of homozygous TBPHDD962/2 L3 loss-of-function larvae,
pan-neuronal Gal4-mediated ELAV.Dcr2, TBPH-IR knock-
down leads to impaired synaptic transmission (compare Sup-
plementary Material, Fig. S10A and B with Fig. 4A, B).
In contrast to pre-synaptic knockdown of TBPH, recordings
at the NMJ of muscle-specific Gal4-mediated BG57.Dcr2,
TBPH-IR L3 knockdown larvae did not reveal any significant
alterations in either amplitude or frequency of mEJPs, when
compared with controls (Supplementary Material, Fig. S10C
and D). Low frequency (0.2 Hz) stimulation of the NMJ
revealed a small but significant difference in evoked EJP ampli-
tudes. However, we did not detect any significant differences in
quantal content in BG57.Dcr2, TBPH-IR L3 knockdown
larvae (Supplementary Material, Fig. S10C and D). Together,
these data demonstrate that altered TBPH function causes de-
fective pre-synaptic transmission at the larval NMJ, suggesting
that impaired pre-synaptic efficacy is one of the earliest events in
the etiology of Drosophila TDP-43-related pathogenesis.
TBPH is essential for neuronal activity
underlying motor behavior
To further dissect TBPH dysfunction, we focused on
cell-type-specific LOF and GOF and carried out TBPH-RNAi
together with Dcr2 targeted by Tubulin-Gal4, which is ubiqui-
tously and constitutively active during development, adulthood
and aging (24), as well as pan-neuronal Elav-Gal4 and
EB1-Gal4 specific to upper motor neurons. Tub.Dcr2,
TBPH-IR mimicked TBPH mutations, causing larval/pupal le-
thality with few adult escapers (data not shown) and a disturbed
tripod gait (Fig. 3I). To rule out thatUAS-Dcr2 itself does cause
a walking phenotype, we analyzed Tub.Drc2 flies which
revealed no differences in walking activity, distance or activity
over time when compared with controls (SupplementaryMater-
ial, Fig. S11). Adult Tub.Dcr2, TBPH-IR flies displayed
impaired motor behavior comparable to TBPHDD962/2 null
mutants with severely reduced walking activity and distance
traveled; their motor behavior remained limited over time
with significantly reduced walking speed (Fig. 5), and walking
was characterized by severe gait abnormalities (Fig. 3I). We
observed similar motor phenotypes with Gal4-mediated
UAS-TBPH-RNAi LOF targeted either to post-mitotic
neurons (Elav.Dcr2, TBPH-IR) or to upper motor neurons
(EB1.Dcr2, TBPH-IR) (Fig. 5). Moreover, analysis of open-
field locomotion revealed that upper motor neuron-specific
TBPH GOF (EB1.TBPH) and upper motor neuron-specific
TBPH-RNAi knockdown (EB1.Dcr2, TBPH-IR), resulted in
similar phenotypes characterized by severely impaired motor
behavior (Figs 3E–H and 5). These data suggest that both tissue-
specific loss and gain of Drosophila TDP-43 function impair
neuronal activity underlying essential motor behavior.
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Figure 3. Both loss and gain of TBPH affect survival and motor behavior. (A) Survival analysis quantified the number of larvae that survived to adulthood. The
number of fully eclosed adults was significantly reduced in loss-of-function (LOF) TBPH null mutants and gain-of-function (GOF) ELAV.TBPH flies, com-
pared with respective control (w1118/+, control A; Elav/+, control B). (B) Both TBPH LOF and GOF show impaired larval locomotion with a reduction in the
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TBPH dysfunction differentially affects synaptic integrity
in an age-related manner
Next we investigated whether impaired synaptic activity
caused by TBPH dysfunction may lead to synaptic alterations
in aging flies. We therefore analyzed brains of aged flies with
or without either UAS-TBPH-IR LOF or UAS-TBPH GOF tar-
geted to EB1-Gal4-specific upper motor neurons. The
EB1-Gal4 driver becomes active during late pupal stages
and remains active during adulthood and aging in a population
of roughly 80 upper motor neurons (ellipsoid body ring
neurons). In contrast to severe motor phenotypes (see
Figs 3E–H and 5G–J), dysfunction or loss of this small popu-
lation of upper motor neurons does not significantly alter the
lifespan of flies and hence is an ideal assay system to study
Drosophila TDP-43 dysfunction at the cellular and synaptic
level (see Figs 6 and 7). We used EB1-Gal4 driven
UAS-TBPH-IR LOF or UAS-TBPH GOF and co-expressed a
membrane-bound form of GFP (UAS-mCD8::GFP) that also
visualizes axons and synaptic terminals, and co-labeled
whole mount brains with anti-Fasciclin 2 (Fas2) that is also
expressed at pre- and post-synaptic sites of the ellipsoid
body ring neuropil (Supplementary Material, Fig. S12).
Analysis of brains of Gal4-mediated upper motor neuron-
specific EB1.Dcr2, TBPH-IR at day 5, 20 and 40 did not
reveal any significant differences at synaptic termini of the
EB ring neuropil based on distribution, intensity, and shape
of mCD8::GFP or Fas2 expression (Supplementary Material,
Fig. S12A–J); however, by day 40, but not at day 5 or day
20, we consistently observed misshapen, fragmented and scat-
tered cell bodies of EB ring neurons, together with a severe re-
duction in the number and fasciculation of axonal projections,
when compared with age-matched controls (Supplementary
Material, Fig. S12E–H, compare with Supplementary Mater-
ial, Fig. S12A–D). In contrast, we observed strong reduction
already by day 5 of mCD8::GFP labeling in cell body mem-
branes, axons and synaptic termini of TBPH GOF brains
(EB1.mCD8::GFP, TBPH), which was more pronounced
by day 40; Fas2 immunoreactivity, however, appeared un-
affected (Supplementary Material, Fig. S12K–T).
To determine in more detail whether the age-related synap-
tic alterations were either pre- or post-synaptic, we made use
of the pre-synaptic marker synaptotagmin fused to GFP (UAS-
Syt::GFP) in combination with the post-synaptic marker
DenMark, a fusion protein of telencephalin and mCherry,
which labels the somatodendritic compartment in Drosophila
(36) (Fig. 6). Analysis of day 5, day 40 and day 50 adult
EB1.Syt::GFP, DenMark controls revealed that expression
of these markers alone did not cause obvious phenotypes
(Fig. 6A–C, I–K, and data not shown). However, when
co-expressed together with UAS-TBPH-IR and UAS-Dcr2 in
upper motor neurons, Gal4-mediated upper motor neuron-
specific EB1.Dcr2, TBPH-IR RNAi-mediated LOF specific-
ally caused down-regulation of both pre-synaptic Syt::GFP
and dendriticDenMark at day 50 (Fig. 6D–F). To rule out prep-
aration or immunolabeling artifacts, independent replicates of
fly brains were similarly processed and analyzed with identical
confocal microscopy settings, which established significant re-
duction of reporter gene expression in pre-synaptic (Fig. 6H)
and post-synaptic compartments when compared with age-
matched controls (Fig. 6G). Similar analyses were carried out
on day 5 and day 40Gal4-mediated uppermotor neuron-specific
GOF flies, with adult EB1.Syt::GFP, DenMark, TBPH flies
showing a down-regulation of both pre-synaptic Syt::GFP and
dendritic DenMark at day 5 and day 40 (Fig. 6L–N) compared
with EB1.Syt::GFP, DenMark controls (Fig. 6I–K). Inde-
pendent replicates of brains were similarly analyzed and
showed a significant reduction of reporter gene expression in
pre-synaptic (Fig. 6P) and post-synaptic compartments when
compared with age-matched controls (Fig. 6O and data not
shown). Together these findings suggest that upper motor
neuron-specific TBPH GOF and RNAi LOF affect synaptic in-
tegrity; in both cases, phenotypes occur in a progressive and
age-related manner, and are associated with severely impaired
motor behavior (Figs 3D–H and 5).
TBPH dysfunction results in age-related and progressive
neurodegeneration
Synaptic deficits and subsequent neurodegeneration are con-
sidered to be hallmarks of ALS and other neurodegenerative
diseases (37,38). We therefore investigated whether TBPH
LOF and GOF can lead to degenerative cell loss. To visualize
and number targeted neurons, we analyzed brains of aged flies
that co-express UAS-mCD8::GFP with or without either
UAS-TBPH-IR LOF or UAS-TBPH GOF again targeted to
EB1-Gal4 specific upper motor neurons (Fig. 7).
Analysis of EB1.mCD8::GFP, Dcr2, TBPH-IR brains at
day 5 and 20 did not reveal any significant differences in
neuron numbers; however, by day 40 and 50, we observed a
significant reduction of targeted EB neurons (Fig. 7G),
showing a worsening of the phenotype over time. For the
remaining EB neurons, mCD8::GFP labeling revealed missha-
pen, fragmented and scattered cell bodies when compared with
age-matched controls (Figs 7D–F, compare with 7A–C).
number of peristaltic waves per minute compared with controls (w1118/+, control A; Elav/+, control B). (C) TBPH LOF and GOF adults also show poor climb-
ing performance in a startle-induced climbing assay (n ¼ 15) compared with controls (w1118/+, control A; Elav/+, control B). (D–H) Video-assisted motion
tracking of TBPHDD962/2 LOF and cell type-specific EB1.TBPH GOF targeted to upper motor neurons. (D) Representative walking tracks recorded over 3 min
for TBPHDD962/2 and EB1.TBPH flies, together with their respective controls (w1118/+, control A; EB1/+, control C). (E–G) TBPHDD962/2 LOF and
EB1.TBPH GOF flies show a reduction in walking activity over time, activity and total distance traveled compared with the respective controls (w1118/+,
control A; EB1/+, control C). (H) TBPHDD962/2 null mutants show reduced walking velocity compared with controls, whereas EB1-specific overexpression
of TBPH does not affect the mean velocity (w1118/+, control A; EB1/+, control C). (I) TBPHDD962/2 LOF, Tub.TBPH-RNAi downregulation and ELAV.
TBPH GOF flies display disturbed tripod gait. Left cartoon shows tripod gait with left foreleg (1), right middle leg (2) and left hind leg (3). Control flies (w1118)
walk in a stereotyped alternating tripod gait pattern. This pattern is disrupted in TBPHDD962/2 null mutants (TBPH2/2), ubiquitous RNAi-mediated TBPH
knockdown flies (Tub.TBPH-RNAi) and pan-neuronal Elav-Gal4-mediated TBPH overexpression flies (ELAV.TBPH). Box-plots show median, upper and
lower quartiles (box); whiskers contain data 1.5× the interquartile range; + indicates a data point within 3× the interquartile range (outliers). ∗∗P, 0.01;
∗∗∗P, 0.001. Mean and SEM are shown (A, E).
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Figure 4. TBPH dysfunction affects synaptic efficacy. (A) Representative excitatory junction potential (EJP) traces are shown for LOF. EJP amplitudes for
TBPHDD962/2 LOF and pan-neuronal ELAV.TBPH GOF flies are not significantly different from the respective controls (control A, w1118/+ and control
B, Elav/+), however, quantal content is significantly increased in TBPH mutant larvae. (B) Representative traces of spontaneous neurotransmitter release
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A comparable but more severe degenerative phenotype was
observed in TBPH GOF. Brains of 5-day-old EB1.
mCD8::GFP, TBPH flies showed reduced mCD8::GFP ex-
pression in perikarya as well as axonal extensions and synaptic
arborizations of ellipsoid body ring neurons. GFP expression
was further reduced by day 40 (Fig. 7K–M, compare with
7H–J) and almost undetectable in day 60 old EB1.
mCD8::GFP, TBPH flies when compared with age-matched
controls. Analysis of independent replicates of brains of age-
matched EB1.mCD8::GFP, TBPH and EB1. mCD8::GFP
flies that were similarly processed and analyzed with identical
confocal microscopy settings, established significant and pro-
gressive, age-related loss of upper motor neurons (Fig. 7N).
To independently confirm age-related and progressive loss
of neurons, we studied pox neuro (poxn) expression, which
is specific to ellipsoid body ring neurons (39). Notably, loss
of poxn-expressing cells progressed between day 5 and day
40 in EB1.mCD8::GFP, TBPH flies (Supplementary Mater-
ial, Fig. S13). In addition to the decrease and subsequent loss
of mCD8::GFP and poxn expression, degenerative cell loss
was confirmed by the specific and age-related decrease in
the number of ellipsoid body ring neurons that expressed ex-
cessive amounts of TBPH in EB1.mCD8::GFP, TBPH
flies (Supplementary Material, Fig. S4 and data not shown).
TUNEL labeling of brains of aged EB1.mCD8::GFP,
TBPH flies did not indicate increased apoptotic activity (Sup-
plementary Material, Fig. S14), suggesting that progressive
loss of upper motor neurons was not caused by programmed
cell death. Together these data suggest that prolonged dys-
function of Drosophila TDP-43 causes age-related and pro-
gressive neurodegeneration.
Gain of TBPH does not downregulate or mislocalize
endogenous TBPH
The phenotypic similarities between tissue-specific TBPH
LOF and GOF may suggest that the observed synaptic deficits,
impaired motor behavior and age-related neurodegeneration
might be due to a common pathogenic mechanism. Previous
in vitro and in vivo studies indicated that TDP-43 regulates
its own expression by a negative feedback loop (17,40,41)
that may participate in a feed-forward mechanism whereby
cytoplasmic aggregation depletes nuclear TDP-43 function,
essentially leading to a loss-of-function phenotype. We
tested this hypothesis and over-expressed UAS constructs
coding for tagged or untagged full length TBPH (Fig. 8).
We utilized GMR-Gal4 and specifically targeted TBPH GOF
to differentiating photoreceptor cells which resulted in a
rough eye phenotype due to photoreceptor cell degeneration
(42) (data not shown). Western blot analysis of heads of
1–3-day-old cases and controls identified a 58 kDa band in
each condition similar to the control (Fig. 8A). Quantification
of independent replicates confirmed that GMR-Gal4 specific
TBPH GOF with C- and/or N-terminal tags did not alter en-
dogenous levels of TBPH expression (Fig. 8B).
We then tested whether GMR-Gal4 specific TBPH GOF
may lead to aggregate formation and/or deplete nuclear ex-
pression, hence affecting the function of endogenous TBPH
without changing overall TBPH protein levels. Third instar
eye imaginal discs were immunolabeled with anti-TBPH and
anti-FLAG or anti-HA and counterstained with DAPI to deter-
mine potential aggregates and nuclear localization. In none of
the cases examined did we detect aggregate formation, nor did
we observe loss or alteration of nuclear TBPH expression
(Fig. 8C–N and data not shown). We also tested whether
GMR-Gal4-specific TBPH GOF may result in ubiquitinated
TBPH and thus render the endogenous protein non-functional
even though expression levels and nuclear localization
appeared unaltered. However, immunolabeling with anti-
FK2, which recognizes poly-ubiquitination, did not reveal
any differences to controls (data not shown). Together these
data suggest that gain of Drosophila TDP-43 function does
not alter its own expression level or localization, although it
results in severe synaptic, behavioral and neurodegenerative
phenotypes.
DISCUSSION
Here we have systematically compared the phenotypic
consequences of loss and gain of TDP-43 function in Dro-
sophila. Our results demonstrate that deregulation of TBPH
affects neuronal function and viability. In either case, deregu-
lated TBPH initiates synaptic deficits and impaired motor be-
havior, ultimately causing age-related and progressive
neurodegeneration. Our findings indicate that common
loss-of-function phenotypes underlie TDP-43 dysfunction in
Drosophila, which has implications for understanding
TDP-43-mediated pathogenesis in ALS and FTLD.
Both loss and gain of TDP-43 trigger disease formation
TDP-43 related ALS and FTLD cases are characterized by
both nuclear clearance and the cytoplasmic accumulation of
full length, truncated and modified forms of TDP-43 (1).
TDP-43 has been shown to autoregulate its own expression
(17,41), and its ubiquitylation, phosphorylation, aggregation,
(mEJP) shown for TBPHDD962/2 LOF. Both the mEJP amplitude and frequency are significantly reduced in TBPH mutant larvae. The mEJP is unaffected in
ELAV.TBPH gain-of-function flies (w1118/+, control A; Elav/+, control B). (C) Representative ERG traces of the indicated TBPH LOF conditions. The white-
eyed TBPHDD962/2 mutants and w1118 flies show a strong, habituating response, steady maintained response and off-transient. The red-eyed OregonR, GMR.-
Shibire-IR and GMR.TBPH-IR show a smaller amplitude response; GMR.Shibire-IR flies lack on- and off transients. Chequered bar indicates duration of light
pulse. (D) Mean peak–peak amplitude of the ERG from the indicated conditions at day 1 and day 5 timepoints. (E) TBPHDD962/2 mutant and GMR.TBPH-IR
have significantly smaller off-transients than the respective eye color-matched controls. The negative GMR.Shibire-IR controls, in which synaptic transmission
is blocked, show a severely reduced off-transient. The solid line shows the regression line between off-transient and maintained response for wild-type flies. (F)
Representative ERG traces of the indicated TBPH GOF conditions. The UAS-TBPH/+ and GMR/+ flies show a normal amplitude response, the smaller response
seen in the GMR/+ flies is due to the darker red pigment. GMR.UAS-TBPH flies have a very small response, with no off/on transients visible. (G) Mean peak–
peak amplitude of the ERG from the indicated GOF conditions at day 1 is significantly decreased in GMR.TBPH flies compared with the controls (D, E, n ¼ 9;
∗P, 0.05, ∗∗P , 0.01, ∗∗∗P , 0.001). Mean and SEM are shown (A, B, D, G).
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truncation, mislocalization, nuclear clearance and defective
autoregulation can contribute either directly or indirectly to
disease formation (12). However, no consensus has emerged
as to whether loss or toxic gain of TDP-43 function, or both,
are causally related to disease onset and progression.
In our study, we systematically compared loss- and gain of
TBPH, the Drosophila homolog of TDP-43, and analyzed their
effect on synaptic function and morphology, motor control and
age-related neuronal survival. Our results demonstrate that
loss of function, RNAi-mediated downregualtion and overex-
pression of wild-type Drosophila TDP-43 are sufficient to
cause age-related neurodegeneration. In the case of TDP-43
overexpression, we did not detect alterations in expression
levels or mislocalization of the endogenous protein; we also
found no evidence for ubiquitylation, aggregation, truncation
or autoregulation, and based on western blot data, excessive
phosphorylation appears unlikely. Our data thus argue that
TDP-43 truncation, modification, altered autoregulation or
aggregates are not a prerequisite for toxicity and age-related
neurodegeneration, which is also supported by data in other
model systems (28,41,43–46).
Previous studies showed that TDP-43 can form homodimers
(47) and functions in multiprotein/RNA complexes (15,48,49)
where multiple TDP-43 molecules are incorporated into each
ribonucleoprotein complex (50). These data suggest that equi-
librated, physiological levels of TDP-43 and a stoichiometric
relationship with ribonucleoprotein complex components are
essential for proper biogenesis, spatio-temporal expression
and hence, regulation of TDP-43 target genes. Our results es-
tablish that deregulation of TDP-43 levels is a core event
underlying disease formation, which can be triggered by
either decreasing or increasing levels of TDP-43. This sug-
gests that de-regulation of TDP-43 levels, by loss of function,
downregulation or overexpression, alters the stoichiometry of
participating components and, hence, ribonucleoprotein
complex formation required for proper physiological function.
In either condition, the net result of de-regulated TDP-43 is
impaired physiological function which, when continuing,
affects neuronal survival, ultimately causing progressive cell
loss. In support of this notion, we determined synaptic deficits
as one of the earliest phenotypes of TDP-43 dysfunction.
Pre-synaptic deficits are early, initiating events of
TDP-43-related pathogenesis
In our study, we found that both loss and gain of Drosophila
TDP-43 result in synaptic deficits and impaired motor behav-
ior, followed by progressive, age-related neurodegeneration.
In contrast to previous reports in Drosophila (27,28,29), we
did not detect any obvious structural defects at the larval
neuromuscular junction or mislocalization of synaptic proteins
that might explain the observed behavioral phenotypes. This
discrepancy might be attributable to differences in genetic
background and/or methods used. Motor terminals are
dynamic structures that show developmental and circadian
fluctuations in shape and size (51). In our study, we used
bona fide TBPH null alleles together with genomic rescue,
as well as overexpression alleles. Instead of structural
defects at the larval NMJ, our experiments reveal that affected
flies are characterized by defective synaptic transmission, a
phenotype detectable both at the larval NMJ and in the
adult. In addition, our tissue-specific RNAi-mediated knock-
down experiments identified pre-synaptic, rather than post-
synaptic deficits as the earliest detectable phenotypes at the
larval NMJ, suggesting that pre-synaptic deficits are initiating
events in disease formation.
Our observations therefore allow for the first time the de-
scription of a sequence of events whereby TDP-43 dysfunction
causes impaired synaptic transmission and motor abnormal-
ities, followed by the subsequent loss of neuronal connections
that precede degenerative cell death in an age-related and pro-
gressive manner. Such a sequence of events suggests that
TDP-43 related pathogenesis progresses from the synapse
and axon to the neuronal cell body, thereby resembling affin-
ities to the ‘dying back’ phenomena, a hallmark of several
neurodegenerative diseases (37). Comparable events have
been, at least to some extent, reported for Wallerian degener-
ation (52), and recent genetic evidence indicates that neuronal
‘dying back’ underlies an active process of self-destruction
distinct from apoptotic cell death (53). A ‘dying back’
process also characterizes human ALS patients and mouse
superoxide dismutase 1 (SOD1) models of ALS (38,54).
Like TDP-43 inclusions, SOD1 mutations are commonly iden-
tified in familial ALS (55). Although further, conclusive
experiments are required, it is tempting to speculate that
TDP-43 might not only regulate RNAs related to synaptic
function (15,17), but potentially also negatively regulates the
transcription or translation of target genes involved in the
active self-destruction of neuronal connections.
TDP-43 dysfunction results in loss-of-function phenotypes
In addition to similarities between loss and gain of function
phenotypes, we also observed phenotypic differences, includ-
ing electrophysiology at the larval NMJ but also at the level of
synaptic integrity and neurodegeneration in adult brain, where
Figure 5. Similar to TBPH mutants, cell-type specific knockdown of TBPH leads to impaired motor behavior. Gal4-mediated UAS-TBPH-RNAi knockdown
targeted either ubiquitously (Tub-Gal4) or to all neurons (Elav-Gal4), or targeted to upper motor neurons (EB1-Gal4). RNAi efficiency was enhanced by
co-expressing UAS-Dcr2. (A–J) Motor behavior analysis using video assisted open-field motion tracking. (A) Representative walking tracks recorded over
30 min for 5-day-old Tub.Dcr2, TBPH-RNAi flies and heterozygous Dcr2,TBPH-RNAi controls. (C–F) Tracking analyses reveal that, comparable to
TBPHDD962/2 mutants, Tub.Dcr2,TBPH-RNAi flies have a significantly reduced average activity, total distance travelled, mean speed and activity over
time when compared with heterozygous Dcr2,TBPH-RNAi controls. (G–J) Dcr2, TBPH-RNAi expression was activated by either the pan-neuronal
ELAV-Gal4 driver, or the EB1-Gal4 driver (ELAV.Dcr2,TBPH-RNAi or EB1.Dcr2,TBPH-RNAi, respectively). Tracking analyses reveal that, comparable
to TBPHDD962/2 mutants, the walking activity, total distance travelled, mean speed and activity over time of 5-day-old ELAV.Dcr2,TBPH-RNAi and EB1.-
Dcr2,TBPH-RNAi flies is significantly reduced when compared with that of the control (heterozygous Dcr2,TBPH-RNAi). Box-plots show median, upper and
lower quartiles (box); whiskers contain data 1.5× the interquartile range; +indicates a data point within 3× the interquartile range (outliers). (n ¼ 24; ∗P ,
0.05, ∗∗P , 0.01, ∗∗∗P , 0.001). Mean and SEM are shown (F, J).
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GOF typically causedmore severe phenotypes than LOF.While
some of these differences might be attributable to differing
efficiencies of UAS/Gal4-mediated LOF andGOF, or a possible
gain of toxic function, it is striking that both conditions lead to
comparable, detrimental phenotypes with similar endpoint:
age-related and progressive neurodegeneration.
It should be emphasized, however, that the similar pheno-
typic outcomes of loss and gain of Drosophila TDP-43
Figure 6. Both cell type-specific TBPH LOF and GOF cause trans-synaptic defects. (A) Expression of pre-synaptic marker Syt::GFP (green) and dendritic
marker DenMark (red) in upper motor neurons of the adult central brain of 50-day-old flies using the ellipsoid body neuron-specific EB1-Gal4 driver (EB1.
Syt::GFP, DenMark). Syt::GFP (green) expression is seen in the pre-synaptic region, whereas DenMark visualizes post-synaptic dendritic compartment.
DenMark signal and Syt::GFP are indicated in single panels (B and C, respectively). (D–F) Driving TBPH-RNAi in EB1 neurons leads to downregulation
of DenMark (E) and Syt::GFP (F). (G) DenMark signal is significantly reduced in TBPH LOF (EB1.Syt::GFP, DenMark, TBPH-IR). (H) TBPH knockdown
significantly downregulates Syt::GFP. (I–K) DenMark (J) and Syt::GFP (K) expression in EB1 neurons of 40-day-old flies. (L and M) TBPH overexpression in
EB1 neurons leads to downregulation of DenMark (M) and Syt::GFP (N). (O) DenMark signal is significantly reduced in TBPH GOF (EB1.Syt::GFP,
DenMark, TBPH). (P) TBPH overexpression significantly downregulates Syt::GFP. ∗P , 0.05, ∗∗P , 0.01, ∗∗∗P , 0.001. Mean and SEM are shown. Scale
bar: 50 mm.
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function, including age-related neurodegeneration, do not ne-
cessarily implicate similar mechanisms related to TDP-43
mediated pathogenesis. It is conceivable but remains to be
shown that loss, downregulation or gain of TDP-43 function
could trigger distinct pathogenic mechanisms that all converge
on a functional node which when defective initiates disease
formation. Previous studies suggest that such a functional
node is likely the stochiometric activity of TDP-43 in ribonu-
cleoprotein complexes that are essential for the regulation and
correct processing of multiple target genes, including those
related to synaptic function (15,17). This model is consistent
with familial cases of ALS and FTLD, were TDP-43 is pre-
dominantly mutated in the C-terminal, prion-like domain
(5–8) that regulates tissue-specific gene expression, transcrip-
tional repression and alternative splicing, and is essential for
binding to ribonucleoproteins involved in microRNA and
mRNA biogenesis, as well as RNA turnover (9,10,12,13).
According to this model, C-terminal, but also RRM mutations
may hinder the participation of TDP-43 in ribonucleoprotein
complex formation and hence, their function, leading to
physiological deficits and eventually neurodegeneration.
In summary, our findings demonstrate that both loss and gain
of TDP-43 function result in functional deficits whereby
impaired synaptic transmission and defective motor behavior
precede progressive deconstruction of neuronal connections, ul-
timately causing age-related neurodegeneration. Our data there-
fore provide in vivo evidence for common loss-of-function
phenotypes underlying TDP-43 dysfunction that likely also
characterize TDP-43-mediated ALS and FTLD.
MATERIALS AND METHODS
Fly stocks
Fly stocks were maintained at 258C on standard cornmeal
food, unless for aging experiments where aged flies
Figure 7. Upper motor neuron-specific RNAi-mediated downregulation and gain of TBPH causes loss of neuronal connections and age-related neurodegenera-
tion. (A–C) Control flies with mCD8::GFP overexpression in upper motor neurons at day 40 (B, enlargement of dashed box in A; C, additional example). (D–F)
TBPH LOF flies (EB1.mCD8::GFP, Dcr2, TBPH-IR) with TBPH-RNAi targeted to upper motor neurons at day 40. The GFP expression in the ellipsoid body
structure does not diminish in the aged brain, however, dispersed cells with fragmented and granular GFP expression are detectable (E, enlargement of dashed
box in D; F, additional example). (G) Quantification of EB1 neuron cell number (GFP positive) in control and TBPH LOF flies at day 5, 40 and 50. A significant
decrease in neuron number is observed in aged TBPH LOF flies. (H–J) Control flies with mCD8::GFP overexpression in EB1 ring neurons at day 40 (I–J,
enlarged example of cell bodies). (K–M) TBPH and mCD8::GFP overexpression in upper motor neurons leads to an age-related reduction in mCD8::GFP ex-
pression (L–M, enlarged example of cell bodies). (N) Quantification of EB1 cell numbers (GFP positive) in control and TBPH GOF flies at day 5, 40 and 60. A
significant decrease in neuron number is observed over time in TBPH GOF flies. ∗∗P, 0.01, ∗∗∗P , 0.001. Mean and SEM are indicated. Scale bar: 50 mm.
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were maintained on 15% sugar/yeast medium (23). The
following strains were used: Oregon R (wild-type); w1118;
w; TBPHnull/CyO,GFP; + (26) Df(2R)106/SM5; w; +;
Elav-Gal4; GMR-Gal4; and Tub-Gal4; UAS-mCD8::GFP
(56); UAS-Dcr2; UAS-Shibire-RNAi (Bloomington Stock
Centre); p{Gawb}C57 (BG57, ref. 34); EB1-Gal4 (57); UAS-
DenMark, UAS-Syt::GFP (36); UAS-RFP-TBPH (58).
Transgenic constructs
The TBPH gene was amplified by PCR from cDNA clone
GH09868 (DGRC). PCR primers to amplify TBPH in
pUAST vector are forward primer: 5′-GGAGATCTATGGA
TTTCGTTCAAGTGTCGG-3′; reverse primer: 5′-GGCTCG
AGTTAAAGAAAGTTTGACTTCTCCGC-3′.
Primers used to generate Flag-TBPH-HA are: forward primer:
5′-GGAGATCTATGGACTACAAGGACGACGATGACAAG
GATTTCGTTCAAGTGTCGG-3′; reverse primer: 5′-GGCTC
GAGTTAGGCATAGTCTGGGACGTCATATGGATAAAG
AAAGTTTGACTTCTCCGC-3′.
BglII and XhoI sites were used to insert TBPH into pUAST
vector. DNA sequence was confirmed by sequencing. The
UAS-TBPHYA765 line was used for all behavioral, electrophysi-
ology and immunohistochemistry experiments. To specifically
knockdown TBPH, the target region was chosen by E-RNAi
web service (59). TBPH RNAi construction was carried out
Figure 8. GMR-Gal4-mediated gain of TBPH does not downregulate or mislocalize endogenous TBPH. (A) Western blot analysis of GMR-Gal4-driven
untagged (58 kDa) or tagged UAS-TBPH (Flag-TBPH-HA, 60 kDa; RFP-TBPH, 85 kDa). Levels of endogenous TBPH (arrow at 58 kDa) are unaffected in
day 1–3 flies overexpressing either form of TBPH. (B) Quantification of endogenous TBPH shows no alteration in TBPH protein levels. Endogenous TBPH
signal intensities were normalized against b-Tubulin. Mean and SEM are indicated. (C, G, K) Third instar eye imaginal discs immunolabeled with anti-TBPH
does not reveal TBPH-positive aggregates in cell bodies nor in the optic stalk (dotted area). (D–F, H–J, L–N) Third instar eye imaginal discs immunolabeled
with anti-TBPH and DAPI identifies that nuclear expression of endogenous TBPH is maintained in gain of TBPH. Note that signal intensity in I, J, M and N is
adjusted for overexpressed TBPH to avoid saturation of the signal. Scale bar: 10 um.
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as previously described (33). PCR primers with EcoRI
(forward) and XbaI (reverse) sites were designed to subclone
TBPH RNAi construct into pMF3 vector (33).
TBPH-RNAi: forward primer: 5′-GGGAATTCCACTCATA
CCACCCACAGGG-3′; reverse primer: 5′-GGTCTAGA
GTTATGCGGCTGGTTCATTC-3′.
Insertion of RNAi construct was confirmed by restriction
enzyme digestion and sequencing. Plasmid injection and gen-
eration of transgenic flies were performed by BestGene Inc
(CA, USA).
To generate a TBPH genomic rescue construct, we used
TBPH genomic DNA from pacman bac library (CH322-
116J04, bacpac.chori.org) covering position 19751906–
19744713 on the second chromosome, which encodes the
entire TBPH coding sequence. TBPHgenomic was integrated
into the pUC 3GLA plasmid (gift from Matthias Soller) by
recombination.TBPHgenomic in pUC3GLAwas used to generate
transgenic flies by site-specific integration into the attp86Fb
fly strain (60) and flies harboring TBPHgenomic pUC 3GLA
were selected by compound eye-specific GFP expression.
P-element-mediated mutagenesis
The TBPHDD96 and TBPHDD100 null alleles were generated by
imprecise excision of the EY10530 P-element, which is
inserted in the promoter region of the TBPH locus. It was
mobilized using HoP1 D2-3 transposase (gift from Iris
Salecker). Four hundred and fifty excision lines were estab-
lished from individual events and genomic deletions within
the TBPH locus were identified by PCR and confirmed as
protein null by western blot. TBPHDD96 and TBPHDD100
breakpoints are 19750093 . . . 19747817 and 19750093 . . .
19747925, respectively. The primers used to confirm
the presence of neighboring gene CG4585 were: forward
primer: 5′-CTGAGCATCTTCTGCGAC-3′; reverse primer:
5′-GAAATTAGCTCGCCATGG-3′.
Breakpoints and P-element insertion sites were sequenced
using the following primers:TBPHDD100, forward primer:
5′-TTCCATGGCGAGCTAATT-3′; reverse primer: 5′- GTG
TCCAGGTTGCGGTACTT-3′ TBPHDD96 forward primer:
5′-CGAGTTGCCGCCGTAAT-3′; reverse primer: 5′-CCTT
TCACTCGCACTTAT-3′. Sequencing was carried out at
MWG Eurofins.
Generation of TBPH antibody
The anti-TBPH antibody was generated by injecting two rabbits
with peptide sequences PQGNHMNPGRNGHHR, correspond-
ing to residues 291–305 and QSSGSQNAAEKSNFL, residues
517–531. Immunization was carried out by Eurogentec.
Immunohistochemistry
Adult and larval CNS dissection was carried out as previously
described (23). Larval NMJ dissections were carried out
according to established protocol (61). Primary antibodies
used were: mouse anti-Repo (1:20); rat anti-Elav (1:30);
mouse anti-Futsch (1:50); mouse 3C11 (1:100); mouse anti-
synaptotagmin (1:25); mouse anti-FasII (1:10); mouse NC82
(anti-bruchpilot) (1:100) and mouse anti-Neuroglian (1:4) all
obtained from the Developmental Studies Hybridoma Bank
(DSHB) under the auspices of the NICHD and maintained
by The University of Iowa; rabbit anti-TBPH antibody
(1:3000); rabbit anti-Poxn (1:100; Adachi, Ludlow & Hirth,
unpublished); mouse anti-polyubiquitin (FK2, 1:200;
ENZO); rabbit anti-FLAG (1:500; Cell Signaling Tech);
mouse anti-HA (1:40; Roche); goat anti-HRPCy3 (1:100; Stra-
tech), 488-Phalloidin (1:1000; Invitrogen). Secondary anti-
bodies were Alexa fluor 488, 568 and 647 (each 1:150;
Invitrogen).
Image acquisition and analysis
Images were obtained either with Motic BA400 or Leica TCS
SP5 confocal microscope with Leica Application Suite
Advanced Fluorescence (LAS AF) version 2.0.2 software.
For confocal images, channels were scanned sequentially.
For comparative images, the same microscope settings were
used for the control and experimental genotypes. For Figs 6
and 7, confocal z-stacks were rendered as 3-D projections.
Signal quantification of digital images was carried out using
Fiji (FIJI). Significance of GFP and FasII signal intensity
was calculated using unpaired Student’s t-test. Equal variance
assumptions were based on Levene’s test for equality of vari-
ance.
NMJ bouton count
Early L1 larvae were picked from 4 h egg collection plates
(fruit agar) and placed on cornmeal food. At wandering L3,
larvae were dissected according to established protocol (61).
All preparations were dissected within a 1.5 h window to
avoid differences in circadian rhythm effect on bouton
number. Z-stacks were taken of the MN6/7-Ib motor neurons
innervating muscle group 6/7 in segment A3. Boutons were
counted by hand and the number of NC82 puncta were ana-
lyzed using the ITCN plug-in for ImageJ.
Terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) assay
Tissues of interest were fixed in 4% formaldehyde and subse-
quently permeabilized in 100 mM Citrate/0.1% Triton X-100
for 30 min at 658C. Tissues were briefly washed with 0.5%
Triton-X 100 in PBS and rinsed twice with TUNEL assay
buffer (In Situ Cell Death Detection Kit; Roche). After incu-
bating for 90 min at 378C, TdT enzyme was added and
further incubated for 3 h at 378C. For positive control,
freshly dissected tissue was soaked in 2N HCl for 30 min to
induce apoptosis.
Western blots
Fly tissue was lysed in RIPA buffer (150 mM NaCl, 1% NP-40,
5 mM EDTA, 0.5% sodium, deoxycholate and 0.1% SDS,
50 mM Tris, pH8.0) containing complete proteinase inhibitor
(Roche) and phosstop phosphatase inhibitor (Roche).
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Samples were centrifuged to take the RIPA-soluble fraction.
SDS–PAGE was run in 8% SDS gel. Rabbit anti-TBPH anti-
body was used at 1:2000–3000 and anti-b-Tub (DSHB) was
used at 1:300. Secondary antibodies were IRDye 800 conju-
gated goat anti-rabbit (1:10000, Rockland Immunochemicals)
and Alexa Fluor 680 goat anti-mouse (1:10000, Invitrogen).
Membrane images were acquired using Odyssey.
Reverse transcriptase PCR
RNA was extracted by homogenizing whole flies in Trizol,
adding chloroform, incubating on ice for 15 min, followed
by centrifugation at 16 000g at 48C. The upper phase was
added to isopropanol and incubated and spun as before. The
pellet was washed in 70% ethanol and dissolved in nuclease-
free H2O. RNA purity was measured using a Nanodrop.
DNase treatment was carried out according to manufacturer’s
instructions (Ambion). cDNA was generated by mixing 1 mg
RNA and random hexamers, heating to 708C and adding
5 ×M-MLV reaction buffer, M-MLV-RT, RNAsin and
dNTPs according to manufacturer’s instructions (Ambion).
Samples were incubated at 378C for 1 h and 708C for
15 min. PCR products were run on 1% agarose gel. The
primers used were as follows; TBPH: forward primer: 5′-
ATCTTGGATGGCTCAGAACG-3′, reverse primer: 5′-GT
CGGTCTTTATTCCGTTGG-3′ RPL32: forward primer:
5′-CGCCGCTTCAAGGGACAGTATC-3′, reverse primer:
5′-CGACAATCTCCTTGCGCTTCTT-3′.
Footprint/gait analysis
Flies were briefly anaesthetized with CO2 and one-third of the
wings were removed to prevent escape. Flies were left to
recover in a petri dish for 10–15 min before being tapped
onto a soot-covered glass microscope slide (slides were held
over a candle flame until covered in an even coating of
soot). Footprints were visualized by lighting the slide from
below and images were captured with a Q-capture camera.
Startle-induced negative geotaxis
Flies’ climbing ability was assayed as described earlier (23).
Equal variance assumptions were based on Levene’s test for
equality of variance.
Eclosion analysis
Embryos were collected on fruit agar plates in 5 h batches and
left in a 258C incubator until larvae had hatched. Fifty first
instar larvae were placed in a vial and a tally made of all
fully eclosed adult flies, mean values were calculated and
plotted as a percentage of total number of larvae picked. Sig-
nificance was calculated using unpaired t-test. This was
carried out in triplicate for each genotype.
Larval motility
Thirty wandering third instar larvae were individually placed
on a fruit agar plate and allowed to recover for 30 s. The
number of peristaltic waves, travelling in either direction,
was scored over 1 min. Significance was calculated using un-
paired t-test (two-tailed). Equal variance assumptions were
based on Levene’s test for equality of variance.
Video-assisted motion tracking
Tracking arenas were modified six-well tissue culture plates
(35 mm diameter wells) filled with silicon rubber (Sylguard)
to leave a 3 mm space so that flies could walk freely but not
hop or fly. 18–24 flies were briefly anaesthetized with CO2,
placed in separate arenas and left to recover at 258C for
45 min before being placed above an array of white LEDs
within a temperature-controlled incubator. Tracking was
carried out at 258C. A black and white CCD camera
(Hitachi, MP-M1A) positioned above the arenas was con-
nected to a PC via an analog capture card (Integral Technolo-
gies, Flashbus MV Lite). Recordings were carried out during
the same time slot. Recorded videos were converted to fly
movie format using the motmot package (62) and loaded
into Ctrax software (63) to analyze the positions of the flies
throughout the video. Position data for the 30 min file was
exported as a Matlab-compatable (Mathworks) matrix file.
Errors in the tracking were fixed using Matlab (Mathworks)
as well as FixErrors GUI (63), which is described in further
detail at http://ctrax.sourceforge.net/fixerrors.html. Fixed tra-
jectories were analyzed in Matlab using custom scripts
(written by D.M.H). This analysis determined the mean vel-
ocity, mean activity, activity over time and mean cumulative
distance traveled by the population of flies in the arena. Activity
was defined as movement per frame above a velocity of 2 mm/
s. Average activity was the percentage of frames where the fly
was active (.2 mm/s velocity). Mean velocity was the average
of velocities in each frame of the recording only when the fly
was active. Box-plots were generated in Matlab where the
boxes show median, upper and lower quartiles; whiskers
contain data 1.5× the interquartile range; + indicates a data
point within 3× the interquartile range. Significance was calcu-
lated using the Mann–Whitney U-test with a Bonferroni correc-
tion to account for multiple comparisons.
Escape response
The amplitude of the escape response was carried out as pre-
viously described (64). In summary, anaesthetized flies were
fixed to a tungsten pin on the end of a cocktail stick using
glue gum. The pin was placed so that it covered the thorax.
Flies were left to recover for 20 min before being mounted
over the flexible ergometer and lowered gently until the flies
reached out and place their legs on the jump platform, bringing
it up to a resting position. A stimulating electrode was placed
in the eye and one in the cervical connective to stimulate the
Giant Fiber System. A supra-threshold 0.8 mV was applied
and as the flies jumped, the amount of beam displacement
was measured.
Electrophysiology
Wandering third instar larvae were dissected in HL3 buffer
(65) containing 1.8 mM CaCl2. Nerves innervating the body
muscle walls were cut near the ventral ganglion and stimulated
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using a suction electrode and isolated pulse stimulator Digiti-
mer DS2A (constant current modification), with a current
double that needed to initiate a compound response. All
recordings for TBPH LOF/GOF and appropriate controls
were made intracellularly in muscle 6, abdominal segment 3,
at ambient room temperature using microelectrodes filled
with 3 M KCl that had tip resistances of 5–10 MV. In 1.8 mM
extracellular Ca2+ resting membrane potentials were
261.1+ 1.0 mV (n ¼ 10) and 255.8+ 2.5 mV (n ¼ 9, P,
0.05) and input resistances were 10.1+ 0.7 MV (n ¼ 10) and
9.6+ 0.4 MV (n ¼ 9, P. 0.05) for w1118 and TBPH2/2
larvae, respectively. Resting membrane potentials were
254.1+ 1.4 mV (n ¼ 7) and 252.0+ 1.5 mV (n ¼ 8, P ¼
0.0018) and input resistances were 5.9+ 0.2 MV (n ¼ 7) and
6.4+ 0.3 MV (n ¼ 8, P, 0.05) for ELAV/+ and ELAV.
TBPH, respectively. Data, filtered at 1 kHz and digitized at
10 kHz, were acquired using an Axopatch 200B amplifier and
a Digidata 1320A data acquisition board (Molecular Devices
Data) were acquired using pClamp8.02 (Molecular Devices)
and analyzed with Clampfit8.02 (Molecular Devices) orMiniA-
nalysis (Synaptosoft). EJP amplitude histograms were con-
structed by averaging 50 separate events stimulated at 0.2 Hz
from an individual muscle cell and then calculating the mean
response from at least six larvae per line. Spontaneous release
events were recorded for 120 s without any electrical stimula-
tion. All events were analyzed and mean mEJP amplitudes
from individual larvae were averaged to generate the histo-
grams. To obtain the frequency of spontaneous release events
the number of events for each recording was divided by 120
and then averaged to generate histograms. Significance was
calculated using unpaired Students t-test (two-tailed).
Electroretinograms
Female flies were aspirated into a pooter, and then gently
blown into a truncated pipette tip. They were restrained with
nail varnish (Creative Nail Design). No anaesthesia was
used. Blunt glass pipettes, filled with simple Drosophila
saline (130 mM NaCl, 4.7 mM KCl, 1.9 mM CaCl2 (66) were
used as recording electrodes, placing one tip centrally on the
surface of the eye and the other in the mouthparts. Flies
were adapted to the dark for 2 min and then presented with
a standard blue light stimulus from three Kingbright,
KAF-5060PBESEEVGC light-emitting diodes (maximum
emission wavelength 465 nm) situated 6 cm away from the
eye. Light pulses were monitored with a BPX65 photodiode
(Centronics) next to the head of the fly. In the dark, the photo-
diode current was 0.5 nA; during the stimuli 400 nA. Each fly
was tested with at least three blue light stimuli, .10 s apart.
Their responses were captured using Dasylab software
(measX, Mo¨nchengladbach, Stuttgart) and the average wave-
form calculated. At least nine flies of each genotype were
tested at each timepoint. Significance was calculated using
Bonferroni post hoc analysis.
Statistical analysis
Statistical analysis was carried out as previously described
(24); for details of the statistical tests used, see Supplementary
Material, Table S1.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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